FDA вводит в действие с июня новые правила маркировки  рецептурных лекарств по их безопасности для репродукции и лактации.

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm425317.htm

Вместо условных букв будут разделы в описании:

-- The "Pregnancy" section will discuss dosing considerations, possible risks to the fetus, and other information relevant to prenatal use. It will also note whether there's a registry that maintains data on how pregnant women are affected by the product.
-- The "Lactation" section will note the amount of drug that may be in breastmilk and the potential effects on the child, among other considerations.
-- The "Females and Males of Reproductive Potential" section will include information about pregnancy testing, contraception, and infertility as it relates to the product.